Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bowen, 1993, Biochemical pharmacology of sigma receptors, 113
Bowen, 1994, Interaction of sigma receptors with signal transduction pathways and effects on second messengers, 139
Bowen, 1989, Evidence for a multi-site model of the rat brain sigma receptor, Eur. J. Pharmacol., 163, 309, 10.1016/0014-2999(89)90200-8
Bowen, 1992, Sigma-1 and sigma-2 binding sites of rat kidney, Soc. Neurosci. Abstr., 18, 456
Bowen, 1992, Inhibition of the cholinergic phosphoinositide response by sigma ligands: distinguishing a sigma receptor-mediated mechanism from a mechanism involving direct cholinergic antagonism, 155
Bowen, 1993, [3H](+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors, Mol. Neuropharmacol., 3, 117
Bruce, 1990, Characterization of “sigma-like” sites in rat liver membranes: further evidence for sigma-1 and sigma-2 sites, Soc. Neurosci. Abstr., 16, 370
Cheng, 1973, Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (150) of an enzymatic reaction, Biochem. Pharmacol., 22, 3099, 10.1016/0006-2952(73)90196-2
de Costa, 1989, Synthesis and evaluation of optically pure [3H](+)-pentazocine, a highly potent and selective radioligand for sigma receptors, FEBS Lett., 251, 53, 10.1016/0014-5793(89)81427-9
de Costa, 1992, Synthesis, characterization and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor, J. Med. Chem., 35, 38, 10.1021/jm00079a004
Di Paolo, 1991, N-Substituted derivatives of normetazocine: differentiation of sigma-1 and sigma-2 receptors, Soc. Neurosci. Abstr., 17, 814
Ferris, 1991, Sigma receptors: from molecule to man, J. Neurochem., 57, 729, 10.1111/j.1471-4159.1991.tb08213.x
He, 1993, Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites, J. Med. Chem., 36, 566, 10.1021/jm00057a006
Hellewell, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res., 527, 244, 10.1016/0006-8993(90)91143-5
Hellewell, 1990, Characterization of “sigma-like” binding sites in rat liver membranes: further evidence for sigma-a and sigma-2 sites, 270
Itzhak, 1990, Sigma binding sites in the brain: an emerging concept for multiple sites and their relevance for psychiatric disorders, Life Sci., 47, 1073, 10.1016/0024-3205(90)90165-N
Itzhak, 1991, Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes, J. Pharmacol. Exp. Ther., 257, 141
Jewell, 1993, Strain differences in rat brain and liver sigma binding: lack of cytochrome P450-2D1 involvement, Eur. J. Pharmacol., 243, 249, 10.1016/0014-2999(93)90182-H
Karbon, 1991, [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes, Eur. J. Pharmacol., 193, 21, 10.1016/0014-2999(91)90195-V
Kavanaugh, 1988, Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2- methyl[4,6-3H]phenyl)guanidine, 85, 2844
Klein, 1991, SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain, Life Sci., 48, 543, 10.1016/0024-3205(91)90469-R
Knight, 1991, The subcellular distribution and pharmacology of the sigma recognition site in the guinea-pig brain and liver, Mol. Neuropharmacol., 1, 71
Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (London), 227, 680, 10.1038/227680a0
Largent, 1984, Psychotomimetric opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, 81, 4983
Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6
Martin, 1976, The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, 517
McCann, 1990, Haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions, Eur. J. Pharmacol. Mol. Pharmacol. Sect., 188, 211, 10.1016/0922-4106(90)90004-H
McCann, 1991, Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF 10,047 binding sites (sigma sites_ from rat liver membranes, J. Pharmacol. Exp. Ther., 257, 547
Monnet, 1993, The cytochromes P-450 are not involved in the modulation of the N-methyl-d-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus, Synapse, 13, 30, 10.1002/syn.890130105
Musacchio, 1988, High affinity dextromethophan sites in guinea pig brain: further charcharacterization and allosteric interactions, J. Pharmacol. Exp. Ther., 247, 424
Masacchio, 1989, Dextromethorphan and sigma ligands: common sites but diverse effects, Life Sci., 45, 1721, 10.1016/0024-3205(89)90510-9
Quirino, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci., 13, 85, 10.1016/0165-6147(92)90030-A
Radesca, 1991, Synthesis and receptor binding of enantiometric N-substituted cis-N-[2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma ligands, J. Med. Chem., 34, 3058, 10.1021/jm00114a015
Ross, 1991, Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450, Pharmacol. Toxicol., 68, 293, 10.1111/j.1600-0773.1991.tb01242.x
Rothman, 1991, Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands, Mol. Pharmacol., 39, 222
Samovilova, 1988, (+)-[3H]SKF 10,047 binding sites in rat liver, Eur. J. Pharmacol., 147, 259, 10.1016/0014-2999(88)90784-4
Su, 1991, Sigma receptors: putative links between nervous, endocrine, and immune systems, Eur. J. Biochem., 200, 633, 10.1111/j.1432-1033.1991.tb16226.x
Tam, 1992, Is the rat brain sigma receptor the same as cytochrome P-450? Haloperidol down-regulates sigma receptors but not cytochrome P-450, Soc. Neurosci. Abstr., 18, 547
Vilner, 1991, Characterization of [3H]DTG and [3H](+)-3-PPP binding sites of NB41A3 neuroblastoma, C6 glioma, and NG108-15 hybrid cells, Soc. Neurosci. Abstr., 17, 593
Vilner, 1992, Characterization of sigma-like binding sites of NB41A3, S-20Y, and N1E-115 neuroblastomas, C6 glioma, and NG108-15 neuroblastoma-glioma hybrid cells: further evidence for sigma-2 receptors, 341
Walker, 1990, Sigma receptors: biology and function, Pharmacol. Rev., 42, 355
Walker, 1993, A comparison of (−)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma-2 receptors in motor function, Eur. J. Pharmacol., 231, 61, 10.1016/0014-2999(93)90684-A
Walker, 1993, Functional role of sigma receptors in the nervous system, 91
Weber, 1986, 1,3-Di((2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma that receptors for psychotomimetic opiates and antipsychotic drugs, 83, 8784
Wu, 1991, Electrophysiological and binding studies on intact NCB-202 cells suggest presence of low affinity sigma receptor, J. Pharmacol. Exp. Ther., 257, 351